Literature DB >> 32015172

Antiepileptic drugs are not independently associated with cognitive dysfunction.

Emma Foster1, Charles B Malpas2, Karena Ye2, Benjamin Johnstone2, Patrick W Carney2, Dennis Velakoulis2, Terence J O'Brien2, Patrick Kwan2.   

Abstract

OBJECTIVE: To test the hypothesis that individual antiepileptic drugs (AEDs) are not associated with cognitive impairment beyond other clinically relevant factors, we performed a cross-sectional study of patients admitted to an inpatient video-EEG monitoring unit.
METHODS: We prospectively enrolled patients admitted to an inpatient specialist epilepsy program between 2009 and 2016. Assessments included objective cognitive function, quality of life subscales for subjective cognitive function, and questionnaires for anxiety and depressive symptoms. Bayesian model averaging identified predictors of cognitive function. Bayesian model selection approach investigated effect of individual AEDs on cognition. Conventional frequentist analyses were also performed.
RESULTS: A total of 331 patients met inclusion criteria. Mean age was 39.3 years and 61.9% of patients were women. A total of 45.0% of patients were prescribed AED polypharmacy, 25.1% AED monotherapy, and 29.9% no AED. Age, seizure frequency, and a diagnosis of concomitant epilepsy and psychogenic nonepileptic seizure were predictors of objective cognitive function. Depression, anxiety, and seizure frequency were predictors of subjective cognitive function. Individual AEDs were not independently associated with impaired cognitive function beyond other clinically relevant variables.
CONCLUSIONS: This study found that no AED was independently associated with cognitive dysfunction. Significant determinants of objective and subjective cognitive dysfunction included seizure frequency and depression, respectively. These findings suggest that optimizing therapy to prevent seizures is not likely to occur at the expense of cognitive function.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32015172     DOI: 10.1212/WNL.0000000000009061

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Chronic pediatric diseases and risk for reading difficulties: a narrative review with recommendations.

Authors:  Donna Perazzo; Ryan Moore; Nadine A Kasparian; Megan Rodts; Tzipi Horowitz-Kraus; Lori Crosby; Brian Turpin; Andrew F Beck; John Hutton
Journal:  Pediatr Res       Date:  2022-02-04       Impact factor: 3.953

2.  Bi-directional association between epilepsy and dementia: The Framingham Heart Study.

Authors:  Maria Stefanidou; Alexa S Beiser; Jayandra Jung Himali; Teng J Peng; Orrin Devinsky; Sudha Seshadri; Daniel Friedman
Journal:  Neurology       Date:  2020-10-23       Impact factor: 9.910

3.  Factors correlated with intracranial interictal epileptiform discharges in refractory epilepsy.

Authors:  Robert J Quon; Stephen Meisenhelter; Richard H Adamovich-Zeitlin; Yinchen Song; Sarah A Steimel; Edward J Camp; Markus E Testorf; Todd A MacKenzie; Robert E Gross; Bradley C Lega; Michael R Sperling; Michael J Kahana; Barbara C Jobst
Journal:  Epilepsia       Date:  2020-12-17       Impact factor: 5.864

Review 4.  Amyloid-β: a potential link between epilepsy and cognitive decline.

Authors:  Michele Romoli; Arjune Sen; Lucilla Parnetti; Paolo Calabresi; Cinzia Costa
Journal:  Nat Rev Neurol       Date:  2021-06-11       Impact factor: 42.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.